Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Net Cash Flow: 2023-2025

Historic Net Cash Flow for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to $57.9 million.

  • Incannex Healthcare's Net Cash Flow rose 2622.20% to $57.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.1 million, marking a year-over-year increase of 655.19%. This contributed to the annual value of $8.9 million for FY2025, which is 155.05% up from last year.
  • Latest data reveals that Incannex Healthcare reported Net Cash Flow of $57.9 million as of Q3 2025, which was up 613.49% from $8.1 million recorded in Q2 2025.
  • In the past 5 years, Incannex Healthcare's Net Cash Flow ranged from a high of $57.9 million in Q3 2025 and a low of -$6.0 million during Q3 2023.
  • Moreover, its 3-year median value for Net Cash Flow was -$2.2 million (2023), whereas its average is $5.6 million.
  • Data for Incannex Healthcare's Net Cash Flow shows a peak YoY soared of 2,622.20% (in 2025) over the last 5 years.
  • Incannex Healthcare's Net Cash Flow (Quarterly) stood at -$2.2 million in 2023, then grew by 29.46% to -$1.5 million in 2024, then surged by 2,622.20% to $57.9 million in 2025.
  • Its last three reported values are $57.9 million in Q3 2025, $8.1 million for Q2 2025, and $4.6 million during Q1 2025.